Atika Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-65,000	Closed	-$1.68M	–	96
2021 Q1	$1.68M	Sell	65,000 -105,247	-62%	-$4.63M	0.17%	87
2020 Q4	$9.1M	Buy	+170,247	New	+$8.45M	0.85%	64
2020 Q3	–	Sell	-100,000	Closed	-$4.32M	–	107
2020 Q2	$4.85M	Buy	+100,000	New	+$4.8M	0.69%	64
2017 Q2	–	Sell	-65,200	Closed	-$2.24M	–	79
2017 Q1	$2.24M	Buy	+65,200	New	+$2.3M	1.18%	43
2016 Q4	–	Hold	0	–	–	–	56
2016 Q3	–	Hold	0	–	–	–	67
2016 Q2	–	Hold	0	–	–	–	62
2016 Q1	–	Hold	0	–	–	–	45
2015 Q4	–	Hold	0	–	–	–	57
2015 Q3	–	Hold	0	–	–	–	59
2015 Q2	–	Sell	-35,000	Closed	-$1.35M	–	68
2015 Q1	$1.14M	Sell	35,000 -83,500	-70%	-$2.87M	0.78%	51
2014 Q4	$3.76M	Sell	118,500 -33,500	-22%	-$950K	2.93%	10
2014 Q3	$3.77M	Sell	152,000 -43,000	-22%	-$1.01M	3.03%	7
2014 Q2	$4.41M	Buy	195,000 +15,300	+9%	+$319K	3.88%	5
2014 Q1	$4.37M	Buy	179,700 +4,725	+3%	+$120K	4.13%	7
2013 Q4	$4.37M	Buy	+174,975	New	+$4.13M	4.21%	4